MGMT and colorectal carcinoma: In conclusion, this is the first study to report a significant correlation between CRC patient survival and promoter methylation of the genes p14ARF, RASSF1A and APC1A, as defined by Pyrosequencing assay (13), as well as a protective role of O6-MGMT methylation.